US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% META $728.08 ▲+0.00% NVDA $233.95 ▲+0.00% TSLA $370.59 ▲+0.00% AMD $633.91 ▲+0.00% SPCX $158.96 ▲+0.00% JNJ $256.03 ▲+0.00%
FinancialContent

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

5.870 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cytek Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
Industry’s First End-to-End Flow Cytometry Platform Covering Panel Design Through Data Analysis 
From Cytek Biosciences, Inc.
Via GlobeNewswire
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
Complementary Technologies Deliver an Integrated, End-to-End Clinical Flow Cytometry Workflow for Laboratories Across Europe 
From Cytek Biosciences, Inc.; Sysmex Europe SE
Via GlobeNewswire
Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings ↗
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock ↗
 
Via Benzinga
News headline image
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek (CTKB) Q2 2026 Earnings Call Transcript ↗
U.S. revenue surged 18% while EMEA declined 8% amid geopolitical pressures. 
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Cytek Biosciences Q2 Earnings Call Highlights ↗
Cytek Biosciences (NASDAQ:CTKB) reported second-quarter 2026 revenue growth of 6% year over year, supported by double-digit gains in the United States and China, while continued weakness in Europe and... 
Via MarketBeat
Topics Earnings
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
New 7-Laser Cytek Borealis™ System With Deep Ultraviolet and Infrared cFluor® Reagents; Cytek Aurora™ Evo System Enhancements for Automation and Workflow Efficiency 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Cytek (CTKB) Q1 2026 Earnings Call Transcript ↗
Cytek (CTKB) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
Anniversary Milestone Highlights Expanded Manufacturing Capacity, Stronger Asia-Pacific Presence, and Measurable Contributions to Global Supply Chain Resilience 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek (CTKB) Q4 2025 Earnings Call Transcript ↗
Cytek (CTKB) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek (CTKB) Q3 2025 Earnings Call Transcript ↗
Cytek (CTKB) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
Supports ISAC in Mission to Extend Flow Cytometry Reach Worldwide; Unveils Programs Offering Instrument Award and Research Grants 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
Spectral Flow Cytometry Pioneer Unveils Innovations Accelerating Efficiency and Discovery 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
Improved Sample Throughput, Automation Capabilities and Updated Hardware Design 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Cytek Biosciences Reports First Quarter 2025 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
Company to Conduct Demonstrations, Educational Workshops and Tutorials at Key Industry Events 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
Increasing Accessibility for Flow Cytometry Applications in Emerging and Established Markets 
From Cytek Biosciences, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >